The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus

  title={The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus},
  author={Patricia Gutierrez-Ontalvilla and Rafael Botella and M Amparo Iborra and Francisco Giner and Damian Negueroles and Jose Cortell and Diana Vicente},
  journal={European Journal of Dermatology},
  pages={430 - 431}
previous reports [1, 5, 10]. Unfortunately, dermatologists very rarely notice this symptom, and in our experience, patients do not report it unless specifically asked. As with pruritus, we found no association between the presence or intensity of skin pain and PASI, sPGA or BSA, but DLQI was significantly higher in participants with skin pain and it increased with pain intensity. The few studies on this topic are consistent with this [10]. Since one of our inclusion criteria was a PASI score… 
Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP?
It is demonstrated that PRP based therapy may exert a relevant role in LS patient management due to its effect on Quality of Life (QoL), sexual function in both gender, and gender-related differences in severity of symptoms and disease age onset.
Development and validation of a short version of the Female Sexual Function Index in the Spanish population
A focus group and the IRT analysis allowed the development of a 6-item Spanish version of the FSFI, which showed good reliability in a group of Spanish women.


The effect of vulvar lichen sclerosus on quality of life and sexual functioning
Of all domains ofQoL, LS interfered most with sexual functioning, and patients who experienced more influence on their QoL had more sexual difficulties, leading to more sexual distress independent of their age.
Interplay of Itch and Psyche in Psoriasis: An Update.
Itch or pruritus is closely related to decreased psychosocial well-being of patients with chronic pruritic skin diseases, including psoriasis, and should therefore be adequately addressed while treating patients with Psoriasis.
Pruritus is an important factor negatively influencing the well-being of psoriatic patients.
Pruritus intensity correlated significantly with patients' quality of life, feelings of stigmatization, stress experienced within a period of one month before psoriasis outbreak, and depressive symptoms.
British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018
The document aims to offer an appraisal of all relevant literature up to July 2017, focusing on any key developments, and address important, practical clinical questions relating to the primary guideline objective.
Prevalence of symptoms experienced by patients with different clinical types of psoriasis
Background  The main dermatology textbooks describe only in passing pruritus in psoriasis and rarely mention other symptoms. A quantification of the presence of symptoms is not available for clinical
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
Several identified unmet needs warrant additional attention and action, including improved severity assessment, PsA screening, patient awareness, and treatment options.
Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire.
Assessment of itch characteristics using a previously validated web-based questionnaire found pleasurable scratching was considered pleasurable in both atopic dermatitis and psoriasis; pleasurability correlated weakly with itch intensity in atopy dermatitis.
Skin pain and skin discomfort is associated with quality of life in patients with psoriasis
Background  Patients with psoriasis commonly report severe sensory skin symptoms, sleep disturbance, psychological distress and impaired health related quality of life (HRQoL). However, the complex
Prevalencia de los trastornos de la sexualidad en mujeres climatéricas: Influencia de la menopausia y de la terapia de reemplazo hormonal
There is a high prevalence of sexual dysfunction in menopausal women among climacteric women and estrogens, either endogenous or exogenous, have a positive influence on sexuality.
The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
The results support the reliability and psychometric (as well as clinical) validity of the Female Sexual Function Index (FSFI) in the assessment of key dimensions of female sexual function in clinical and nonclinical samples and suggest important gender differences in the patterning of femaleSexual function in comparison with similar questionnaire studies in males.